Nomura Asset Management
GEVA

Nomura Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Nomura Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,000
Closed -$683K – 934
2015
Q1 		$683K Buy
+7,000
New +$741K 0.01% 745

Nomura Asset Management's GEVA Position: Q2 2015 in Review

Nomura Asset Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 7,000 shares — an estimated $683K sold.

Nomura Asset Management first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $683K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Nomura Asset Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Nomura Asset Management sold 7,000 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $683K.
  • Nomura Asset Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Nomura Asset Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $683K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Nomura Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.